Longitudinal analysis of T-helper cell phenotypes in renal-transplant recipients undergoing growth hormone therapy

Transplantation

Volumn 78, Issue 12, 2004, Pages 1792-1801

  Melk, Anette ^a   Daniel, Volker ^a   Mehls, Otto ^b   Opelz, Gerhard ^a   Tönshoff, Burkhard ^b  

^a UNIVERSITY OF HEIDELBERG   (Germany)

^b UNIVERSITY HOSPITAL HEIDELBERG   (Germany)

Author keywords

Cytokines; Pediatric renal transplantation; Recombinant human growth hormone; T helper cells

Indexed keywords

CELL ADHESION MOLECULE; HUMAN GROWTH HORMONE;

ADOLESCENT; ADULT; ALLOGRAFT; ARTICLE; CELLULAR IMMUNITY; CHILD; CONTROLLED STUDY; DRUG SAFETY; FEMALE; FLOW CYTOMETRY; GRAFT SURVIVAL; GROWTH RETARDATION; HELPER CELL; HORMONAL THERAPY; HUMAN; HUMAN CELL; IMMUNOMODULATION; KIDNEY TRANSPLANTATION; LONGITUDINAL STUDY; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RECIPIENT; T LYMPHOCYTE ACTIVATION;

ADOLESCENT; CD4-CD8 RATIO; CHILD; CHILD, PRESCHOOL; CYCLOSPORINE; CYTOKINES; FEMALE; GROWTH DISORDERS; HUMAN GROWTH HORMONE; HUMANS; KIDNEY FAILURE, CHRONIC; KIDNEY TRANSPLANTATION; LONGITUDINAL STUDIES; MALE; PHENOTYPE; RECOMBINANT PROTEINS; T-LYMPHOCYTES, HELPER-INDUCER;

EID: 11144304547     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.TP.0000147785.11967.1D     Document Type: Article

References (44)

1. Fine RN. Growth following solid-organ transplantation. Pediatr Transplant 2002; 6: 47.
2. Tönshoff B, Mehls O. Factors affecting growth and strategies for treatment in children after renal transplantation. Pediatr Transplant 1997; 1: 176.
3. Sarwal MM, Yorgin PD, Alexander S, et al. Promising early outcomes with a novel, complete steroid avoidance immunosuppression protocol in pediatric renal transplantation. Transplantation 2001; 72: 13.
4. Haffner D, Schaefer F, Nissel R, et al. Effect of growth hormone treatment on the adult height of children with chronic renal failure. German Study Group for Growth Hormone Treatment in Chronic Renal Failure. N Engl J Med 2000; 343: 923.
5. Hokken-Koelega AC, Stijnen T, de Jong RC, et al. A placebo-controlled, double-blind trial of growth hormone treatment in prepubertal children after renal transplant. Kidney Int Suppl 1996; 53: S128.
6. Maxwell H, Rees L. Randomised controlled trial of recombinant human growth hormone in prepubertal and pubertal renal transplant recipients. British Association for Pediatric Nephrology. Arch Dis Child 1998; 79: 481.
7. Guest G, Berard E, Crosnier H, et al. Effects of growth hormone in short children after renal transplantation. French Society of Pediatric Nephrology. Pediatr Nephrol 1998; 12: 437.
8. Fine RN, Stablein D, Cohen AH, et al. Recombinant human growth hormone post-renal transplantation in children: a randomized controlled study of the NAPRTCS. Kidney Int 2002; 62: 688.
9. Friedman AL. Growth hormone is not safe for children with renal transplants. J Pediatr 1997; 131: S25.
10. Lesniak MA, Roth J, Gorden P, et al. Human growth hormone radioreceptor assay using cultured human lymphocytes. Nat New Biol 1973; 241: 20.
11. Rapaport R, Sills IN, Green L, et al. Detection of human growth hormone receptors on IM-9 cells and peripheral blood mononudear cell subsets by flow cytometry: correlation with growth hormone-binding protein levels. I Clin Endocrinol Metab 1995; 80: 2612.
12. Benfield MR, Vail A, Waldo FB, et al. The effect of rhGH in vitro on donor-specific hyporesponsiveness in pediatric transplantation. Pediatr Transplant 1997; 1: 90.
13. Murphy WJ, Longo DL. Growth hormone as an immunomodulating therapeutic agent. Immunol Today 2000; 21: 211.
14. Dobashi H, Sato M, Tanaka T, et al. Growth hormone restores glucocorticoid-induced T cell suppression. FASEB J 2001; 15: 1861.
15. Lebl J, Sediva A, Frisch H, et al. Lymphocyte subsets in renal transplant recipients during growth hormone therapy. Endocr Regul 1999; 33: 3.
16. Takagi K, Suzuki F, Barrow RE, et al. Recombinant human growth hormone modulates Th1 and Th2 cytokine response in burned mice. Ann Surg 1998; 228: 106.
17. Romagnani S. Th1 and Th2 in human diseases. Clin Immunol Immunopathol 1996; 80: 225.
18. Liew FY. T(H)1 and T(H)2 cells: a historical perspective. Nat Rev Immunol 2002; 2: 55.
19. Strom TB, Roy-Chaudhury P, Manfro R, et al. The Th1/Th2 paradigm and the allograft response. Curr Opin Immunol 1996; 8: 688.
20. Waaga AM, Gasser M, Kist-van Holthe JE, et al. Regulatory functions of self-restricted MHC class II allopeptide-specific Th2 clones in vivo. J Clin Invest 2001; 107: 909.
21. Tönshoff B, Haffner D, Mehls O, et al. Efficacy and safety of growth hormone treatment in short children with renal allografts: three year experience. Members of the German Study Group for Growth Hormone Treatment in Children with Renal Allografts. Kidney Int 1993; 44: 199.
22. Tönshoff B, Dietz M, Haffner D, et al. Effects of two years of growth hormone treatment in short children with renal disease. The German Study Group for Growth Hormone Treatment in Chronic Renal Failure. Acta Paediatr Scand Suppl 1991; 379: 33.
23. Schwartz GJ, Brion LP, Spitzer A. The use of plasma creatinine concentration for estimating glomerular filtration rate in infants, children, and adolescents. Pediatr Clin North Am 1987; 34: 571.
24. Sanchez CP, Salem M, Ettenger RB. Changes in cyclosporine A levels in pediatric renal allograft recipients receiving recombinant human growth hormone therapy. Transplant Proc 2000; 32: 2807.
25. Kelso A. Th1 and Th2 subsets: paradigms lost? Immunol Today 1995; 16: 374.
26. Richter A, Lohning M, Radbruch A. Instruction for cytokine expression in T helper lymphocytes in relation to proliferation and cell cycle progression. J Exp Med 1999; 190: 1439.
27. Bird JJ, Brown DR, Mullen AC, et al. Helper T cell differentiation is controlled by the cell cycle. Immunity 1998; 9: 229.
28. Slifka MK, Rodriguez F, Whitton JL. Rapid on/off cycling of cytokine production by virus-specific CD8+ T cells. Nature 1999; 401: 76.
29. Ke B, Shen XD, Zhai Y, et al. Heme oxygenase 1 mediates the immunomodulatory and antiapoptotic effects of interleukin 13 gene therapy in vivo and in vitro. Hum Gene Ther 2002; 13: 1845.
30. Otto C, Kauczok J, Martens N, et al. Mechanisms of tolerance induction after rat liver transplantation: intrahepatic CD4(+) T cells produce different cytokines during rejection and tolerance in response to stimulation. J Gastrointest Surg 2002; 6: 455.
31. Shirwan H. Chronic allograft rejection. Do the Th2 cells preferentially induced by indirect alloantigen recognition play a dominant role? Transplantation 1999; 68: 715.
32. Tan L, Howell WM, Smith JL, et al. Sequential monitoring of peripheral T-lymphocyte cytokine gene expression in the early post renal allograft period. Transplantation 2001; 71: 751.
33. Libetta C, Rampino T, Dal Canton A. Polarization of T-helper lymphocytes toward the Th2 phenotype in uremic patients. Am J Kidney Dis 2001; 38: 286.
34. Yokoyama T, Nitta K, Futatsuyama K, et al. Identification of T helper cell subsets in continuous ambulatory peritoneal dialysis patients. Nephron 2001; 89: 215.
35. Severini G, Diana L, Di Giovannandrea R, et al. Influence of uremic middle molecules on in vitro stimulated lymphocytes and interleukin-2 production. ASAIO J 1996; 42: 64.
36. Lonnemann G, Novick D, Rubinstein M, et al. Interleukin-18, interleukin-18 binding protein and impaired production of interferon-gamma in chronic renal failure. Clin Nephrol 2003; 60: 327.
37. Girndt M. Humoral immune responses in uremia and the role of IL-10. Blood Purif 2002; 20: 485.
38. Liddle C, Goodwin BJ, George J, et al. Separate and interactive regulation of cytochrome P450 3A4 by triiodothyronine, dexamethasone, and growth hormone in cultured hepatocytes. J Clin Endocrinol Metab 1998; 83: 2411.
39. Jurgens G, Lange KH, Reuther LO, et al. Effect of growth hormone on hepatic cytochrome P450 activity in healthy elderly men. Clin Pharmacol Ther 2002; 71: 162.
40. Oellerich M, Armstrong VW. Two-hour cyclosporine concentration determination: an appropriate tool to monitor Neoral therapy? Ther Drug Monit 2002; 24: 40.
41. Tönshoff B, Heinrich U, Mehls O. How safe is the treatment of uraemic children with recombinant human growth hormone? Pediatr Nephrol 1991; 5: 454.
42. Maxwell H, Amlot P, Rees L. Growth hormone and markers of immune function in children with renal transplants. Pediatr Nephrol 2000; 14: 473.
43. Girndt M, Köhler H, Schiedhelm-Weick E, et al. T cell activation defect in hemodialysis patients: evidence for a role of the B7/CD28 pathway. Kidney Int 1993; 44: 359.
44. Broyer M. Results and side-effects of treating children with growth hormone after kidney transplantation-a preliminary report. Pharmacia and Upjohn Study Group. Acta Paediatr Suppl 1996; 417: 76.